Izokibep improves multiple psoriatic arthritis symptoms in phase 2 studyJune 5, 2022Psoriatic Arthritis
Serum brodalumab levels linked with treatment outcomes in patients with psoriasisJune 2, 2022Psoriatic Arthritis
Abortion debate may affect Rx decisions for pregnant womenMay 27, 2022Lupus & Connective Tissue DiseasesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
‘Shielding’ status provides best indicator of COVID-19 mortality in U.K. arthritis populationMay 16, 2022COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Reduced-frequency methotrexate monitoring causes no harmMay 10, 2022Rheumatoid ArthritisPsoriatic Arthritis
Upadacitinib earns FDA approval for ankylosing spondylitis May 2, 2022Ankylosing spondylitisPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Parents’ autoimmune diseases may affect children’s developmentMay 2, 2022Psoriatic ArthritisRheumatoid Arthritis
Long-term efficacy, safety data for ixekizumab in pediatric psoriasis reportedApril 25, 2022Psoriatic ArthritisPediatrics
Secukinumab’s antipsoriatic effects confirmed in U.S. patient populationApril 25, 2022Psoriatic Arthritis
Hypocaloric diet controls joint activity in psoriatic arthritis – regardless of weight lossApril 14, 2022Psoriatic Arthritis
Apremilast has neutral effect on vascular inflammation in psoriasis studyApril 8, 2022Psoriatic ArthritisMixed Topics
